Alan B Scott, MD
ABS
Director and Senior Scientist at The Strabismus Research Foundation (SRF).
Senior Scientist at Eidactics.
Senior Scientist at The Smith-Kettlewell Eye Research Institute (SKERI).

Office: 37 Avon Avenue • Mill Valley • CA • 94941

Lab: 2000 Van Ness Avenue • Suite 210 • San Francisco • CA • 94109


Honors

Phi Beta Kappa
Linksz Medal of the International Strabismological Association
Senior Honor Award of the American Academy of Ophthalmology
Costenbader Lecturer, American Association for Pediatric Ophthalmology and Strabismus
Harvey Thorpe Lecturer, Pittsburgh Ophthalmology Society
Hall of Fame Award, Benign Essential Blepharospasm Research Foundation
Proctor Lecturer, Association for Research in Vision and Opthalmology
Marshall M. Parks Lecturer, American Academy of Ophthalmology
Howe Medal, American Ophthalmological Society

Training & Experience

Hospital Staff Appointment, California Pacific Medical Center, San Francisco, CA (1961-present).
Executive Director, Smith-Kettlewell Eye Research Institute, San Francisco, CA (1992-2003)
Co-Director, Smith-Kettlewell Eye Research Institute, San Francisco, CA (1980-1992).
Senior Scientist (Clinical), Smith-Kettlewell Eye Research Institute, San Francisco, CA (1960-present).
M.D., University of California Medical School, San Francisco, CA (1956).
A.B. in Medical Science, University of California, Berkeley, CA (1953).

Grants & Awards

PVF
Principal Investigator, Pacific Vision Foundation (1 Oct 2013 - 30 Sep 2014): "Accurate Injection of Eye Muscles in Children"
NEI

Principal Investigator, NIH/NEI Project 1 R01 EY018633-01 (1 Sep 2009 - 31 Aug 2014): "Extraocular Muscle (EOM Responses to Bupivacaine Injection"
PVF
Principal Investigator, Pacific Vision Foundation (1 Oct 2008 - 30 Sep 2009): "Bupivacaine in Underperforming Muscles"
Myotox
Principal Investigator, The Smith-Kettlewell Eye Research Institute (1 Jan 2008 - 31 Dec 2008): "Studies of Extraocular Muscle Function"

Professional Citizenship
NEI
Visual Sciences Study Section B, National Institutes of Health, Bethesda, MD (1983-1986).

Visual Research Program Committee, National Institutes of Health, Bethesda, MD (1978-1982).
ISA
Administrative Council, International Strabismological Association, (1978-1986).

Selected Peer-Reviewed Publications

PDF
Scott AB, Miller JM, Danh KK (2013). Bupivacaine shortens eye muscles and corrects strabismus. Presentation at 149th Annual Meeting, American Ophthalmological Society. San Diego, CA, USA. (Supplemental Video).
PDF
Scott AB, Miller JM, Danh KK (2013). Bupivacaine injection of eye muscles to treat strabismusPediatric Ophthalmology and Strabismus, Hoyt CS, Taylor D, ch 87, pgs 896-900, pub Elsevier.
PDF
Miller JM, Scott AB, Danh KK, Strasser D, Sane M (2012). Bupivacaine injection remodels extraocular muscles & corrects comitant strabismusOphthalmology, vol 120, isu 12, pgs 2733-2740. (Authors' Cut PDFPublisher's site).
PDF
Scott AB, Miller JM, Shieh BS (2009). Treating strabismus by injecting the agonist muscle with bupivacaine and the antagonist with botulinum toxin. Transactions of the American Ophthamological Society, vol 107, pgs 104-109.
PDF
Scott AB, Miller JM, Shieh BS (2009). Bupivacaine injection of the lateral rectus muscle to treat esotropiaJournal of AAPOS, vol 13, pgs 119-122.
PDF
Scott AB, Alexander DE, Miller JM. Bupivacaine Injection of Eye Muscles to Treat Strabismus. Br J Ophthalmol. 2007; 91(2): 146-8.
PDF
Morad Y, Kowal L, Scott AB. Lateral Rectus muscle disinsertion and reattachment to the lateral orbital wallBr J Ophthalmol. 2005; 89(8): 983-5.
PDF
Souza-Dias C, Scott AB, Wang AH. Progressive restrictive strabismus acquired in infancy. Br J Ophthalmol. 2005; 89(8): 986-7.
PDF
Scott AB. Development of botulinum toxin therapy. In: Dermatol Clin. 2004 Apr;22(2):131-3.
PDF
McNeer KW, Magoon EH, Scott AB. Chemodenervation therapy: Techniques and indications. In: Clinical Strabismus Management. Rosenbaum, Santiago (eds.), W.B. Saunders Co.: Philadelphia 1999; Chapter 32: 423-32.
PDF
Scott AB. Botulinum toxin treatment of strabismus. In: Strabismus. Consejo Latinoamericano de Estrabismo (CLADE) 1998; 77-83.
Unavailable
Scott AB. Preventing ptosis after botulinum treatment. [In blepharospasm] Ophthalmic, Plastic and Reconstructive Surgery 1997; 13(2), 81-83.
PDF
Scott AB. Adaptations of the oculomotor system. In: Proceedings of CLADE (Consejo Latino-Americano de Estrabismo), XII Congress, Buenos Aires, Prieto-Diaz J (ed.), May, 1996; 509-11.
Unavailable
Scott AB. Botulinum toxin treatment of ocular alignment disorders. In: Proceedings of the International Conference on Biomedical Aspects of Clostridial Neurotoxins. Oxford, July 7-11, 1996.
PDF
Scott AB. Posterior fixation: adjustable and without posterior sutures. In: Update on Strabismus and Pediatric Ophthalmology: Transactions of the Joint Congress, June 19-23, 1994.
PDF
Tyler CW, Scott AB. Binocular Vision. In: Duane's Foundations of Clinical Ophthalmology. Tasman, Jaeger (eds.), J.B. Lippincott Co.: Philadelphia 1994; Chapter 24: 643-71.
PDF
Scott AB. Change of eye muscle sarcomeres according to eye positionJ Pediatr Ophthalmol Strabismus. 1994 Mar-Apr; 31(2): 85-8.
PDF
Scott AB. Botulinum and Tetanus Neurotoxins: Neurotransmission and Biomedical Aspects. Das Gupta BR (ed.), Plenum Press, New York 1993; 557-8.
PDF
Scott AB, Miller JM, Collins CC. Eye muscle prosthesisJ Ped Ophthalmol Strabis. 1992; 29: 216-8.
PDF
Scott AB, Magoon EH, McNeer K, Stager DR. Botulinum treatment of childhood strabismus. In: Strabismus and Ocular Motility Disorders. Campos EC (ed.), The Macmillan Press Ltd. 1990; 403-7.
PDF
Scott AB. Botulinum toxin treatment of strabismus. In: Strabismus and Ocular Motility Disorders. Campos EC (ed.), The Macmillan Press Ltd. 1990; 401-2.
PDF
Scott AB. Botulinum treatment of strabismus following retinal detachment surgery. Arch Ophthalmol. 1990; 108: 509-10.
Unavailable
Scott AB. Botulinum toxin / role in ophthalmology. Focal Points: Clinical Modules for Ophthalmologists, 1989; 7: module 12.
PDF
Scott AB. Antitoxin reduces botulinum side effects [In blepharospasm]Eye, 1988; 2(1): 29-32.
Unavailable
Magoon E, Scott AB. Botulinum toxin chemodenervation in infants and children: an alternative to incisional strabismus surgeryJ. Pediatr. 1987; 110: 719-22.
Unavailable
Scott AB. Botulinum treatment for blepharospasm. In: Ophthalmic Plastic and Reconstructive Surgery. Smith BC (ed.), St. Louis: Mosby Co. 1986; 609-613.
PDF
Scott AB, Kennedy RA, Stubbs HA. Botulinum toxin injection as a treatment for blepharospasmArch Ophthalmol. 1985; 103: 347-50.
PDF
Scott AB, Kraft SP. Botulinum toxin injection in the management of lateral rectus paresisOphthalmology, 1985; 92(5): 676-683.
Unavailable
Scott AB. Injection treatment of endocrine orbital myopathyDocum Ophthalmol. 1984; 58: 141-145.
PDF
Scott AB. Botulinum Toxin Injection of Eye Muscles to Correct Strabismus. Transactions of the Am. Ophthalmol. Society, 1981; 79: 734-70.
PDF
Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgeryOphthalmology 1980; 87: 1044-9.
PDF
Scott AB. Ocular Motility. In: Physiology of the Human Eye and Visual System. Records R (ed.), Hagerstown: Harper & Row 1979; 577-642.
PDF
Scott AB. Upshoots & downshoots. In: Smith-Kettlewell Symposium on Basic Sciences in Strabismus. Annex to V Congress of CLADE. Souza-Dias C (ed.), Sao Paolo: Edicoes Loyola 1978; 60-5.
PDF
Scott, AB. Disinserted extraocular muscles. (Identification by muscle stimulation) Am J Ophthalmol. 1975 Feb;79(2):289-91.